I should add, that grant money gets paid in quarterly...

I should add, that grant money gets paid in quarterly instalments & not in one lump sum. So it's going to be tight if cash receipts don't increase substantially.

Mr Marcovich also works for W2V.

Ely Marcovich - Managing Partner & Co-Founder - 360m | LinkedIn

These are his services.

360m Strategic Consulting

Strategic Consulting | Services (360m.tech)

Board member of W2V.

David Assia - iAngels

Perhaps they can come up with something with all this knowledge & experience.

Below is our newest shareholder who's probably spent hundreds of thousands of dollars buying up W2V shares. From memory Regal had around 15M at one point, it could have been more. He bought up the vast majority of Regal's shares as they dumped.

This is proof Peter owns Irwin Biotech Nominees.

DIGITALX LIMITED (ASXCC) - Ann: Change of Director's Interest Notice, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Mr. Peter Rubinstein | GeneType | Genetic Technologies

Peter Rubinstein - Chairman Of The Board - Genetic Technologies Limited | LinkedIn

Who we are (digitalx.com)

Below is the T20 for W2V as of March 2023, with Peter at number 5. He wasn't in the T20 last year.



Poalim Equity is still holding.

Home Page | Capital market (poalimequity.com)